Market closed
Phreesia/$PHR
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Phreesia
Phreesia Inc is a provider of comprehensive software solutions that improves the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, but not limited to, initial patient contact, registration, appointment scheduling, payments, and post-appointment patient surveys.
Ticker
$PHR
Sector
Trading on
NYSE
Industry
Health Care Technology
Headquarters
Employees
1,438
Website
Phreesia Metrics
BasicAdvanced
$1.3B
Market cap
-
P/E ratio
-$1.78
EPS
0.94
Beta
-
Dividend rate
Price and volume
Market cap
$1.3B
Beta
0.94
52-week high
$29.16
52-week low
$14.55
Average daily volume
357K
Financial strength
Current ratio
1.774
Quick ratio
1.403
Long term debt to equity
3.331
Total debt to equity
6.574
Interest coverage (TTM)
-40.64%
Management effectiveness
Return on assets (TTM)
-16.64%
Return on equity (TTM)
-40.26%
Valuation
Price to revenue (TTM)
3.229
Price to book
5.13
Price to tangible book (TTM)
13.46
Price to free cash flow (TTM)
-50.227
Growth
Revenue change (TTM)
22.10%
Earnings per share change (TTM)
-37.90%
3-year revenue growth (CAGR)
29.50%
3-year earnings per share growth (CAGR)
16.82%
What the Analysts think about Phreesia
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Phreesia stock.
Phreesia Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Phreesia Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Phreesia News
AllArticlesVideos
Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results
Business Wire·2 weeks ago
Phreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration
Business Wire·3 weeks ago
Phreesia Joins the Network Advertising Initiative as a Member, Demonstrating Ongoing Commitment to Industry-Leading Privacy Practices
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Phreesia stock?
Phreesia (PHR) has a market cap of $1.3B as of November 15, 2024.
What is the P/E ratio for Phreesia stock?
The price to earnings (P/E) ratio for Phreesia (PHR) stock is 0 as of November 15, 2024.
Does Phreesia stock pay dividends?
No, Phreesia (PHR) stock does not pay dividends to its shareholders as of November 15, 2024.
When is the next Phreesia dividend payment date?
Phreesia (PHR) stock does not pay dividends to its shareholders.
What is the beta indicator for Phreesia?
Phreesia (PHR) has a beta rating of 0.94. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.